Literature DB >> 3018165

Neurotensin stimulates inositol phospholipid metabolism and calcium mobilization in murine neuroblastoma clone N1E-115.

R M Snider, C Forray, M Pfenning, E Richelson.   

Abstract

Murine neuroblastoma cells (clone N1E-115) possess neurotensin receptors that mediate cyclic GMP synthesis. Because of the hypothesized relationship between phospholipid metabolism, intracellular Ca2+, and cyclic GMP synthesis, we determined with these cells the effects of neurotensin on 32P labeling of phospholipids, release of inositol phosphates, and intracellular Ca2+ (as determined with the use of Quin-2, a fluorescent probe sensitive to free Ca2+ levels). Neurotensin stimulated incorporation of 32P into phospholipids, especially phosphatidylinositol and phosphatidate. Neurotensin also stimulated the release of [3H]inositol phosphates with an EC50 of about 1 nM. Mean basal Ca2+ concentration in these cells was 134 nM and this level was increased in a rapid and dose-dependent manner by neurotensin, with an EC50 of 4 nM. Since the EC50 for neurotensin in stimulating cyclic GMP synthesis is 1.5 nM and the KD for binding of [3H]neurotensin at 0 degrees C is 11 nM, all these different effects appear to be shared proximal consequences of neurotensin receptor activation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3018165     DOI: 10.1111/j.1471-4159.1986.tb00742.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  12 in total

1.  High affinity neurotensin receptor mRNA distribution in rat brain and peripheral tissues. Analysis by quantitative RT-PCR.

Authors:  M Méndez; F Souazé; M Nagano; P A Kelly; W Rostène; P Forgez
Journal:  J Mol Neurosci       Date:  1997-10       Impact factor: 3.444

2.  Rational design of novel neurotensin mimetics: discovery of a pharmacologically unprecedented agent exhibiting concentration-dependent dual effects as antagonist and full agonist.

Authors:  Y P Pang; J Zaidi; A P Kozikowski; B Cusack; E Richelson
Journal:  J Comput Aided Mol Des       Date:  1994-08       Impact factor: 3.686

Review 3.  Neurotensin receptors: binding properties, transduction pathways, and structure.

Authors:  J P Vincent
Journal:  Cell Mol Neurobiol       Date:  1995-10       Impact factor: 5.046

4.  Neurotensin inhibition of the hyperpolarization-activated cation current (Ih) in the rat substantia nigra pars compacta implicates the protein kinase C pathway.

Authors:  L Cathala; D Paupardin-Tritsch
Journal:  J Physiol       Date:  1997-08-15       Impact factor: 5.182

Review 5.  Emerging treatments in Neurogastroenterology: relamorelin: a novel gastrocolokinetic synthetic ghrelin agonist.

Authors:  M Camilleri; A Acosta
Journal:  Neurogastroenterol Motil       Date:  2014-12-29       Impact factor: 3.598

6.  Activation of mitogen-activated protein kinase couples neurotensin receptor stimulation to induction of the primary response gene Krox-24.

Authors:  C Poinot-Chazel; M Portier; M Bouaboula; N Vita; F Pecceu; D Gully; J G Monroe; J P Maffrand; G Le Fur; P Casellas
Journal:  Biochem J       Date:  1996-11-15       Impact factor: 3.857

Review 7.  Calmodulin mediates melatonin cytoskeletal effects.

Authors:  G Benítez-King; F Antón-Tay
Journal:  Experientia       Date:  1993-08-15

8.  Characterization of the effect of SR48692 on inositol monophosphate, cyclic GMP and cyclic AMP responses linked to neurotensin receptor activation in neuronal and non-neuronal cells.

Authors:  F Oury-Donat; O Thurneyssen; N Gonalons; P Forgez; D Gully; G Le Fur; P Soubrie
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

9.  Glucocorticoid inhibition of growth in rats: partial reversal with the full-length ghrelin analog BIM-28125.

Authors:  Giovanni Tulipano; John E Taylor; Heather A Halem; Rakesh Datta; Jesse Z Dong; Michael D Culler; Irene Bianchi; Daniela Cocchi; Andrea Giustina
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

10.  Expression of a rat neurotensin receptor in Escherichia coli.

Authors:  R Grisshammer; R Duckworth; R Henderson
Journal:  Biochem J       Date:  1993-10-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.